| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $401.9M | +9.8% |
| Cost of Revenue | $5.4M | +2.0% |
| R&D Expense | $131.0M | +15.0% |
| SG&A Expense | $152.8M | +24.9% |
| Operating Income | $112.6M | -9.5% |
| Pre-tax Income | $116.2M | -7.1% |
| Income Tax | $14.8M | +18.2% |
| Net Income | $101.4M | -9.9% |
| EPS (Basic) | $0.95 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.3M | -14.5% |
| Accounts Receivable | $31.1M | +12.4% |
| Inventory | $6.1M | +22.3% |
| Current Assets | $499.3M | +87.4% |
| Total Assets | $583.4M | +37.7% |
| Current Liabilities | $72.5M | +52.5% |
| Total Liabilities | $81.6M | +70.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $120.3M | -28.3% |
| Capital Expenditures | $413K | -11.9% |
| Investing Cash Flow | -$114.3M | -184.0% |
| Financing Cash Flow | -$17.3M | +94.3% |
| Free Cash Flow | $119.9M | -28.4% |
| -2.1% |
| EPS (Diluted) | $0.87 | -2.2% |
| Stockholders' Equity |
| $501.8M |
| +33.5% |